mRNA technology
The latest news about mRNA technology: headlines, AI summaries and the full story from every source.
- Moderna Upgrades 2026 Revenue Guidance Following Positive Phase 3 Cancer Vaccine Results
- Arcturus Therapeutics Announces Phase II Dosing Timeline for ARCT-2601 and LUNAR 2.0 Platform Advancements
- Moderna's Ebola Vaccine Candidate Selected for WHO-Recommended Phase 2/3 Trial
- AstraZeneca Explores Development of mRNA Cancer Vaccines
- Moderna Stock Surges Over 14% on New Cancer Research Initiative
- Wall Street Analysts Remain Cautious on Moderna Stock Despite Recent Gains
- Moderna Shares Rise Over 12% to Reach New 52-Week High
- Moderna's Cancer Vaccine Shows Promising Phase 3 Results
- Moderna's Stock Soars Over Fivefold This Year Amid Clinical Milestones
- Moderna's Recent Surge Amid Cancer Vaccine Trial Success
- Moderna Stock Surges 127% on Positive Cancer Vaccine Trial Results
- Biotech Stocks Reach Post-Pandemic High Following Moderna's Trial Success
- Moderna Shares Surge on Positive Cancer Vaccine Trial Data
- Moderna Stock Surges Over 170% YTD but Faces Analyst Skepticism
- Moderna Stock Has Doubled This Year Amid Upcoming FDA Decision on Influenza Vaccine
- Moderna's mRNA Flu Shot Could Signal a Turnaround for Investors
- Moderna's Flu Vaccine Application Set for FDA AdCom Review
- Pfizer Outperforms Moderna in Post-COVID Earnings
- CureVac Files Patent Infringement Lawsuit Against Moderna Over mRNA Vaccine Technology